North American Scientific gets FDA nod for breast cancer device

Radiation therapy products developer North American Scientific Inc. (NASI.O: Quote, Profile, Research) said it received U.S. regulatory marketing approval for its high-dose rate radiation treatment design of ClearPath, a breast cancer treatment device. The company had received clearance from the Food and Drug Administration to market the low-dose rate system in April. (Reporting by Ankur Relia in Bangalore) --Click the title of this post to read the full article from its source--